Ligand profile
A3S
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: VK055_0276 — threonine--tRNA ligase
Identifiers
Database identifiers and provenance.
- Ligand ID
A3S- PDB
1tky- UniProt (similar protein)
P0A8M3- Target protein
- VK055_0276
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 194.7
- −1 ≤ LogP ≤ 5 -3.54
- MW ≤ 500 Da 353.3
- LogP ≤ 5 -3.54
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 11
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 194.7
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CO)N)O)Nc1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)NC(=O)[C@H](CO)N)O)N
InChI=1S/C13H19N7O5/c14-5(1-21)12(24)19-7-6(2-22)25-13(9(7)23)20-4-18-8-10(15)16-3-17-11(8)20/h3-7,9,13,21-23H,1-2,14H2,(H,19,24)(H2,15,16,17)/t5-,6+,7+,9+,13+/m0/s1InChI=1S/C13H19N7O5/c14-5(1-21)12(24)19-7-6(2-22)25-13(9(7)23)20-4-18-8-10(15)16-3-17-11(8)20/h3-7,9,13,21-23H,1-2,14H2,(H,19,24)(H2,15,16,17)/t5-,6+,7+,9+,13+/m0/s1
ITDKSTILAWHDJI-AYEBZEFBSA-NITDKSTILAWHDJI-AYEBZEFBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- PDB
- Binding sites
- PF07973
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand A3S →
- PDB RCSB structure 1tky →
- UniProt UniProt P0A8M3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “A3S”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_0276.
PDB 11
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 28
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).